» Articles » PMID: 36273661

Ferroptosis in Heart Failure

Overview
Date 2022 Oct 23
PMID 36273661
Authors
Affiliations
Soon will be listed here.
Abstract

With its complicated pathobiology and pathophysiology, heart failure (HF) remains an increasingly prevalent epidemic that threatens global human health. Ferroptosis is a form of regulated cell death characterized by the iron-dependent lethal accumulation of lipid peroxides in the membrane system and is different from other types of cell death such as apoptosis and necrosis. Mounting evidence supports the claim that ferroptosis is mainly regulated by several biological pathways including iron handling, redox homeostasis, and lipid metabolism. Recently, ferroptosis has been identified to play an important role in HF induced by different stimuli such as myocardial infarction, myocardial ischemia reperfusion, chemotherapy, and others. Thus, it is of great significance to deeply explore the role of ferroptosis in HF, which might be a prerequisite to precise drug targets and novel therapeutic strategies based on ferroptosis-related medicine. Here, we review current knowledge on the link between ferroptosis and HF, followed by critical perspectives on the development and progression of ferroptotic signals and cardiac remodeling in HF.

Citing Articles

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects.

Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.

PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.


IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3.

Dong H, Zhu L, Sun J, Chen Q, Liu P, Zhang W Front Immunol. 2025; 16:1535554.

PMID: 39975542 PMC: 11836015. DOI: 10.3389/fimmu.2025.1535554.


Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer.

Li Y, Liu C, Fang B, Chen X, Wang K, Xin H J Transl Med. 2024; 22(1):1137.

PMID: 39710702 PMC: 11663363. DOI: 10.1186/s12967-024-05881-6.


Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway.

Han Q, Shi J, Yu Y, Yuan H, Guo Y, Liu X Front Pharmacol. 2024; 15:1497733.

PMID: 39600362 PMC: 11589554. DOI: 10.3389/fphar.2024.1497733.


Improving understanding of ferroptosis: Molecular mechanisms, connection with cellular senescence and implications for aging.

De Leon-Oliva D, Boaru D, Minaya-Bravo A, De Castro-Martinez P, Fraile-Martinez O, Garcia-Montero C Heliyon. 2024; 10(21):e39684.

PMID: 39553553 PMC: 11564042. DOI: 10.1016/j.heliyon.2024.e39684.


References
1.
Snodgrass R, Zezina E, Namgaladze D, Gupta S, Angioni C, Geisslinger G . A Novel Function for 15-Lipoxygenases in Cholesterol Homeostasis and CCL17 Production in Human Macrophages. Front Immunol. 2018; 9:1906. PMC: 6117383. DOI: 10.3389/fimmu.2018.01906. View

2.
Wang J, Deng B, Liu Q, Huang Y, Chen W, Li J . Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death Dis. 2020; 11(7):574. PMC: 7382480. DOI: 10.1038/s41419-020-02777-3. View

3.
Ursini F, Maiorino M . Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med. 2020; 152:175-185. DOI: 10.1016/j.freeradbiomed.2020.02.027. View

4.
Li S, Lei Z, Yang X, Zhao M, Hou Y, Wang D . Propofol Protects Myocardium From Ischemia/Reperfusion Injury by Inhibiting Ferroptosis Through the AKT/p53 Signaling Pathway. Front Pharmacol. 2022; 13:841410. PMC: 8966655. DOI: 10.3389/fphar.2022.841410. View

5.
Fuhrmann D, Mondorf A, Beifuss J, Jung M, Brune B . Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis. Redox Biol. 2020; 36:101670. PMC: 7452134. DOI: 10.1016/j.redox.2020.101670. View